IDEAS home Printed from https://ideas.repec.org/h/spr/intchp/978-3-319-30948-4_5.html
   My bibliography  Save this book chapter

Antitrust and Compulsory Licensing in BRICS and Developing Countries

In: Competition Law Enforcement in the BRICS and in Developing Countries

Author

Listed:
  • Rafael Pinho Morais

    (FCE-UERJ)

Abstract

Compulsory licensing is a powerful tool for broadening access to inventions protected by intellectual property rights without the rights owner consent, and is highly disciplined by International Law and individual countries legislation. Although compatible with the WTO rules, compulsory licensing has rarely been used despite being an available competition policy instrument (i.e. antitrust remedy) in most jurisdictions. It can in particular be a powerful policy tool—as concerns pharmaceuticals—to address the well-known health burden held by the population in the poorer nations. While compulsory licensing unambiguously improves access to (existent) health treatments and to protected technologies in general, its impact on profits and innovation rates is a more controversial issue. The economic literature has minimized the arguments against the use of the instrument, but competition policy has been too shy in using such a powerful tool, in particular in BRICS and other developing countries. This chapter overviews the lag between the possible and the actual use of compulsory licensing as an antitrust sanction and of mandatory licensing as a condition for merger approval, in particular in the BRICS and other developing countries.

Suggested Citation

  • Rafael Pinho Morais, 2016. "Antitrust and Compulsory Licensing in BRICS and Developing Countries," International Law and Economics, in: Frederic Jenny & Yannis Katsoulacos (ed.), Competition Law Enforcement in the BRICS and in Developing Countries, pages 149-167, Springer.
  • Handle: RePEc:spr:intchp:978-3-319-30948-4_5
    DOI: 10.1007/978-3-319-30948-4_5
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    More about this item

    Keywords

    Compulsory Licensing; Antitrust; Competition Policy; BRICS; Pharmaceuticals;
    All these keywords.

    JEL classification:

    • L4 - Industrial Organization - - Antitrust Issues and Policies
    • L41 - Industrial Organization - - Antitrust Issues and Policies - - - Monopolization; Horizontal Anticompetitive Practices
    • O34 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:intchp:978-3-319-30948-4_5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.